Mayne Pharma shares fell as much as 7 per cent on Wednesday after it told investors it had received notice from private ...

Mayne Pharma says its US-based suitor Cosette Pharmaceuticals suitor has not yet sent it a termination notice but may still proceed with pulling out of a proposed $672 million takeover of the ...

These shares are having a good time on hump day. But why? The post Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares ...

Mayne Pharma shares posted their worst day in 16 years on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a ...

Drug company Mayne Pharma is counter-suing TherapeuticsMD (TXMD) on breach of contract and fraud allegations and has also ...

Mayne Pharma shares have surged, recovering from yesterday's deep losses, after a Deloitte evaluation backed US-based Cosette Pharmaceuticals' $672 million acquisition of the company. The numbers : ...

Global Growth Forecast Cut: OECD revised global growth from 3.3% in 2024 to 2.9% in 2025 (down from 3.1%) and 2.9% in 2026 ...

Cosette Pharmaceutical's $600 million offer for Mayne Pharma looks imperilled after the bidder raised concerns about "adverse ...

The post-pandemic trend of patients returning to their GPs has abated, but face-to-visits are holding up relative to telehealth.

The Australian sharemarket extended its gains on Wednesday amid optimism for more rate cuts after the Reserve Bank lowered ...